According to a research report from Orient Securities, strategic adjustments by multinational corporations in recent years are expected to reshape the global agrochemical value chain. Chinese companies are poised to venture into high-value-added segments on both sides of the "smile curve," seizing a new phase of structural growth opportunities. The global agrochemical value chain is undergoing a new round of reshaping, and Chinese enterprises are already positioned at the forefront of this trend. The firm is optimistic about the opportunity for Chinese domestic agrochemical companies to enter the high-value-added ends of the global smile curve amid the strategic adjustments of traditional multinationals, thereby reshaping the value chain landscape. The main points from Orient Securities are as follows:
Industry Narrative Shifts from Price Hikes to Overseas Growth
Recent weak market performance in the agrochemical sector stems from dashed expectations regarding the sustainability of the recent price increases. The market is concerned about a return to long-term oversupply and sluggishness, with few investment highlights absent further price catalysts. While China's pesticide industry holds about 70% of global active ingredient capacity, with nearly 90% for export, it has long been confined to the mid-section of the smile curve—the raw material supply segment. Continued domestic capacity expansion in recent years has turned the traditional commodity export path into a homogenous, fiercely competitive battlefield. The rising proportion of formulated product exports might merely represent a passive shift from domestic to international competition, urgently requiring a new paradigm to break the deadlock. However, the firm believes that structural growth opportunities within the industry will lead to a new round of value discovery. Investment value will shift from a pure cyclical price increase logic to a focus on differentiated overseas growth. With strategic adjustments by multinational corporations in recent years, the global agrochemical value chain is poised for reshaping, offering Chinese companies the chance to enter high-value-added segments on both sides of the smile curve and win a new period of structural growth opportunities.
Strategic Retrenchment by Multinational Giants Creates New High-Value Overseas Opportunities
For a long time, traditional multinational agrochemical giants have controlled the high-value-added ends of the smile curve. However, in recent years, they have begun strategic retrenchment in their agrochemical businesses through measures like divestitures, spin-offs, and production line closures. Large organizations are difficult to turn around. High operational costs stemming from their organizational structures support demands for higher profit margins. Historically, the high gross margins of multinationals primarily originated from their innovative product capabilities and end-market brand strength, but both dimensions are now showing signs of fatigue. On the innovation front, developing a single compound takes over 12 years and costs more than $300 million, with the number of new compound launches significantly down from peak levels. Furthermore, R&D intensity in the agricultural segments of core players is not increasing but rather declining, as resources are also being allocated to seeds and digital agriculture, crowding out compound innovation. On the brand front, the expansion of Chinese generic pesticide capacity suppresses product profitability, and low overseas grain prices are forcing farmers to switch to more cost-effective product portfolios. The traditional brand premium bubble is being punctured, forcing giants to exit relatively low-return business lines. What appears to be a full defensive posture is, in reality, a struggle to maintain position.
Chinese Companies Stand at the Historical Node of Value Chain Reshaping
Demand does not disappear; it merely shifts. Domestic companies pursuing differentiated development paths are gradually ascending to the stage at both ends of the smile curve, crafting a new paradigm for China's agrochemical global expansion with an entrepreneurial spirit. On the innovation front, the overseas commercialization of domestically developed novel compounds is at a critical 0-to-1 inflection point. For instance, Taihe Co., Ltd.'s cyproflanilide has reached a global cooperation agreement with UPL, and Jiangshan Agrochemical & Chemicals' benzpyrimoxan is being co-developed for overseas markets with Syngenta. These products have been launched around the end of last year and the beginning of this year, potentially achieving the global commercialization of China-originated products while filling the gap left by multinational giants' shortage of new compounds. On the brand operation front, companies like Rainbow Agrosciences Co., Ltd. represent a deep dive into operational expansion overseas. Based on long-term overseas residency mechanisms, the company has accumulated a significant number of global self-registrations and is gradually iterating towards higher gross margin models, product portfolios, and regional structures in the commercialization phase. Unlike traditional commodity exports, overseas expansion in pesticide branding requires frontline market perception and global risk management capabilities—a path with few domestic precedents, necessitating independent exploration. The team and cultural confidence Rainbow has built through "learning by doing" represent the most valuable assets for Chinese companies going global.
The global agrochemical value chain is undergoing a new round of reshaping, and Chinese enterprises are already positioned at the forefront of this trend.
Risk Warnings
Market progress may fall short of expectations; uncertainties in overseas operations and cost volatility risks; changes in underlying assumptions may affect calculation results.